Chemoinformaics analysis of (+)-Cis-Abscisic-Acid
| Molecular Weight | 264.321 | nRot | 3 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 10 |
| Exact Molecular Weight | 264.136 | nRing | 1 |
| Solubility: LogS | -2.465 | nHRing | 0 |
| Solubility: LogP | 2.342 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 41.5939 |
| nHD | 2 | BPOL | 21.8001 |
| QED | 0.605 |
| Synth | 3.792 |
| Natural Product Likeliness | 2.722 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.026 |
| HIA | 0.021 |
| CACO-2 | -5.187 |
| MDCK | 0.0000248 |
| BBB | 0.572 |
| PPB | 0.79896 |
| VDSS | 0.343 |
| FU | 0.0919085 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.334 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.087 |
| CYP2c9-inh | 0.355 |
| CYP2c9-sub | 0.613 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.27 |
| CL | 1.678 |
| T12 | 0.881 |
| hERG | 0.016 |
| Ames | 0.012 |
| ROA | 0.691 |
| SkinSen | 0.945 |
| Carcinogencity | 0.375 |
| EI | 0.142 |
| Respiratory | 0.811 |
| NR-Aromatase | 0.424 |
| Antiviral | Yes |
| Prediction | 0.845488 |